How Dr. Scott Rocklage Provides Leadership in the Biotechnology Industry

Scott Rocklage, Ph.D., is the Managing Partner of 5AM Ventures, a venture capitalist firm in Boston, MA. He first joined this company in 2003 as a Venture Partner and he became the Managing Partner the following year. 5AM Ventures is a company that specializes at investing in startup biotechnology companies. Like Dr. Scott Rocklage, the team at 5AM Ventures have extensive backgrounds in biotechnology which enables them to spot good companies to invest in.

Dr. Rocklage got his start in the biotechnology industry in research and development. He performed r & d at two firms, Catalytica and Salutar. After a number of years he transitioned to an executive role. He has been the CEO and President of another biotech firm, Nycomed Salutar. He had also joined Cubist Pharmaceuticals where he was the CEO and Chairman of the Board. He earned his Ph.D. in Chemistry at MIT while he earned his bachelor’s in that field from the University of California.

One of the things that sets 5AM Ventures apart as a venture capitalist firm is that the executives take on management roles in the companies they invest in. This lends these startup with leaders who have decades of experience in the industry that can help them grow and develop their medical products. Dr. Scott Rocklage has served as the Executive Chairman of a number of pharmaceutical companies such as Ilypsa, Miikana, and Semprus. He is presently serving as Board Chairman at Cidara, Kinestral, Novira Therapeutics, Inc., and Rennovia, Inc.

As a very busy business professional, every day is different for Dr. Scott Rocklage. He has said that he spends some days deep in research while other days he attends board meetings all day long. He also spends some days working closely with the management teams that run the companies 5AM Ventures are invested in and learn more about Scott.

One of the biggest trends in the pharmaceutical industry that Dr. Rocklage finds interest in is in targeted drug therapies. These types of therapies target specific mutations. The result is that they kill diseased cells while leaving healthy cells undamaged. This type of therapy is being used more and more in treating cancer and Scott’s lacrosse camp.

Leave a Reply

Name *
Email *
Website